• Portfolio
    • People
    • Resources
    Menu
    You
    • Pitango Portfolio
    • First
    • Growth
    • HealthTech
    Us
    • Investment Team
    • First
    • Growth
    • HealthTech
    • Value-Add Platform
    • Venture Partners
    • Fund Operations
    • Support Team
  • Resources
  • The Growth Playbook
  • Sustainability Knowledge Hub
  • Contact Us
  • Novel solution for heart failure patients

    • linkedin
    • email
    • website

    You

    David Israeli, CEO   |  Ehud Schwammenthal   |  Yosi Tuval

    Us

    Zeev Binman

    Facts:

    • Founded in 2012
    • Partnered in 2012
    The Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) is a self-expanding, percutaneous heart pump, intended to provide temporary mechanical circulatory support for the left ventricle (LV) during high-risk percutaneous coronary interventions (HR-PCI) and in patients admitted with cardiogenic shock (CS). The Elevate™ Pump is delivered sheathed into the LV through various commercial 10 Fr femoral introducer sheaths, fully over-the-wire (0.018”). Once in the LV, the self-expanding pump is un-sheathed, expanding from 9 Fr to 30 Fr. The Elevate™ System was successfully evaluated in First-in-Human and US Early Feasibility Study (EFS) studies of HR-PCI patients. A US HR-PCI Pivotal Study against Impella is commencing in 2025.

      © Pitango Ltd. — All Rights Reserved

      • Privacy Policy
      • Terms of Use
      we support DI
      • Home
      • Contact Us
        • LP Login
      Design by israelit  •  Dev by entry.
      Dyslexic View
      Dyslexic View

      Cookies

      Our website uses cookies to provide your browsing experience and relavant informations. Before continuing to use our website, you agree and accept of our Cookie Policy & Privacy

      Accept